PathosAI
AI-enabled precision oncology biotech for accelerating drug development51-200 EmployeesActively Hiring
PathosAI Funding
$365M
11 round
PathosAI is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $365M. Their most recent funding was raised on May 15, 2025.
Funding Rounds
D
$365000000